Cellular and molecular mechanisms in the long-term action of antidepressants.
Open accessAbstract
The hypotheses on the pathophysiology of depression/mood disorders and on antidepressant mechanisms have greatly changed in recent years. The classical monoamine hypothesis was revealed to be simplistic, in that it could not explain the temporal delay in the therapeutic action of antidepressants. Converging lines of evidence have shown that adaptive changes in the several mechanisms of neuroplasticity are likely to be the cellular and molecular correlates of therapeutic effect. In this article, several mechanisms of neuroplasticity are analyzed in relation to the mechanism of antidepressants, ranging from changes in gene expression (including neurotrophic mechanisms), to synaptic transmission and plasticity, and neurogenesis. We propose that the current version of the hypothesis of antidepressant mechanism simply be called the "hypothesis of neuroplasticity". In the final section, we also briefly review the main current novel strategies in the pharmacology of depression and the new putative targets for antidepressants, with particular emphasis on nonmonoaminergic mechanisms.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Tricyclics, MAO inhibitors, and SSRIs all increase synaptic levels of monoamines in the brain within minutes, while it takes weeks before the antidepressant effects become apparent.
“Tricyclics, MAO inhibitors, and SSRIs all increase synaptic levels of monoamines in the brain within minutes, while it takes weeks before the antidepressant effects become apparent (Figure 1) (4, 9).”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [4]
The “Monoamine hypothesis of depression: inconsistencies” section supports the contrast between increased synaptic monoamine availability and an antidepressant effect that takes several weeks. It says monoamine availability increases in a matter of hours, however, not within minutes. No page number is available in our copy. (LLM, conf=0.90)
Experimental — accuracy not yet measuredThe primary issue with the monoamine hypothesis of depression lies in the temporal discrepancy between the acute effects of traditional antidepressants and their delayed therapeutic responses.
“the primary issue with the monoamine hypothesis of depression lies in the temporal discrepancy between the acute effects of traditional antidepressants and their delayed therapeutic responses”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120 · see citing works
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · see citing works
Gage, F. H. (2000) · Science · doi:10.1126/science.287.5457.1433 · Cited by 3,949 · see citing works
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856 · see citing works
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766 · see citing works
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375 · see citing works
Subgenual prefrontal cortex abnormalities in mood disorders
Drevets, W. C., Price, J. L., Simpson, J. R., Todd, R. D., Reich, T., Vannier, M., & Raichle, M. E. (1997) · Nature · doi:10.1038/386824a0 · Cited by 2,693 · see citing works
Transcriptional regulation by the phosphorylation-dependent factor CREB
Mayr, B., & Montminy, M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35085068 · Cited by 2,587 · see citing works
Synaptic Plasticity: Multiple Forms, Functions, and Mechanisms
Citri, A., & Malenka, R. C. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301559 · Cited by 2,323 · see citing works
Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
Berton, O., McClung, C. A., DiLeone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M., et al. (2006) · Science · doi:10.1126/science.1120972 · Cited by 2,129 · see citing works
Function and regulation of CREB family transcription factors in the nervous system
Lonze, B. E., & Ginty, D. D. (2002) · Neuron · doi:10.1016/s0896-6273(02)00828-0 · Cited by 2,127 · see citing works
Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms
Pittenger, C., & Duman, R. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301574 · Cited by 1,795 · see citing works
Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., & Nestler, E. J. (2006) · Nature Neuroscience · doi:10.1038/nn1659 · Cited by 1,780 · see citing works
New approaches to antidepressant drug discovery: beyond monoamines
Berton, O., & Nestler, E. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1846 · Cited by 1,589 · see citing works
Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus
Cameron, H. A., & Mckay, R. D. G. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1040 · Cited by 1,585 · see citing works
The stressed hippocampus, synaptic plasticity and lost memories
Kim, J. J., & Diamond, D. M. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn849 · Cited by 1,543 · see citing works
Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477 · see citing works
Sheline, Y. I., Sanghavi, M., Mintun, M. A., & Gado, M. H. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05034.1999 · Cited by 1,382 · see citing works
Carlezon, W. A., Duman, R. S., & Nestler, E. J. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.06.005 · Cited by 1,351 · see citing works
Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior
Chen, Z.-Y., Jing, D., Bath, K. G., Ieraci, A., Khan, T., Siao, C.-J., Herrera, D. G., Toth, M., Yang, C., McEwen, B. S., et al. (2006) · Science · doi:10.1126/science.1129663 · Cited by 1,340 · see citing works
Neuroimaging studies of mood disorders
Drevets, W. C. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01020-9 · Cited by 1,313 · see citing works
New insights into BDNF function in depression and anxiety
Martinowich, K., Manji, H., & Lu, B. (2007) · Nature Neuroscience · doi:10.1038/nn1971 · Cited by 1,221 · see citing works
Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons
Watanabe, Y., Gould, E., & McEwen, B. S. (1992) · Brain Research · doi:10.1016/0006-8993(92)91597-8 · Cited by 1,212 · see citing works
Adult hippocampal neurogenesis in depression
Sahay, A., & Hen, R. (2007) · Nature Neuroscience · doi:10.1038/nn1969 · Cited by 1,206 · see citing works
Bito, H., Deisseroth, K. A., & Tsien, R. W. (1996) · Cell · doi:10.1016/s0092-8674(00)81816-4 · Cited by 1,123 · see citing works
Calcium regulation of neuronal gene expression
West, A. E., Chen, W. G., Dalva, M., Dolmetsch, R., Kornhauser, J., Shaywitz, A. J., Takasu, M., Tao, X., & Greenberg, M. (2001) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.191352298 · Cited by 1,115 · see citing works
Current advances and trends in the treatment of depression
Blier, P., & de Montigny, C. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90315-8 · Cited by 1,113 · see citing works
Maeng, S., Zarate, C. A., Du, J., Schloesser, R. J., McCammon, J., Chen, G., & Manji, H. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.028 · Cited by 1,103 · see citing works
Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine
Eisenhofer, G., Kopin, I. J., & Goldstein, D. S. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.1 · Cited by 1,072 · see citing works
Mouse and rat <i>BDNF</i> gene structure and expression revisited
Aid, T., Kazantseva, A., Piirsoo, M., Palm, K., & Timmusk, T. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21139 · Cited by 943 · see citing works
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Sanacora, G., Zarate, C. A., Krystal, J. H., & Manji, H. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2462 · Cited by 894 · see citing works
The antidepressant fluoxetine restores plasticity in the adult visual cortex
Vetencourt, J. F. M., Sale, A., Viegi, A., Baroncelli, L., De Pasquale, R., F. O'Leary, O., Castrén, E., & Maffei, L. (2008) · Science · doi:10.1126/science.1150516 · Cited by 890 · see citing works
The role of the hippocampus in the pathophysiology of major depression
Campbell, S., & MacQUEEN, G. M. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0441 · Cited by 879 · see citing works
Hippocampal neurogenesis in adult Old World primates
Gould, E., Reeves, A. J., Fallah, M., Tanapat, P., Gross, C. G., & Fuchs, E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.5263 · Cited by 815 · see citing works
Subtype-Specific Alterations of γ-Aminobutyric Acid and Glutamatein Patients With Major Depression
Sanacora, G., Gueorguieva, R. V., Epperson, C. N., Wu, Y., Appel, M., Rothman, D. L., Krystal, J. H., & Mason, G. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.705 · Cited by 796 · see citing works
Development of β-adrenergic receptor subsensitivity by antidepressants
Banerjee, S. P., Kung, L. S., Riggi, S. J., & Chanda, S. K. (1977) · Nature · doi:10.1038/268455a0 · Cited by 722 · see citing works
The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death
Sapolsky, R. M. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00971-9 · Cited by 699 · see citing works
Depression: a case of neuronal life and death?
Duman, R. S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.033 · Cited by 612 · see citing works
Increased Levels of Glutamate in Brains from Patients with Mood Disorders
Hashimoto, K., Sawa, A., & Iyo, M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.017 · Cited by 609 · see citing works
Metabotropic glutamate receptors as novel targets for anxiety and stress disorders
Swanson, C. J., Bures, M., Johnson, M. P., Linden, A.-M., Monn, J. A., & Schoepp, D. D. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1630 · Cited by 607 · see citing works
Regulation of transcription factors by neuronal activity
West, A. E., Griffith, E. C., & Greenberg, M. E. (2002) · Nature reviews. Neuroscience · doi:10.1038/nrn987 · Cited by 604 · see citing works
Johannessen, M., Delghandi, M. P., & Moens, U. L. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.05.001 · Cited by 586 · see citing works
Moghaddam, B. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb13387.x · Cited by 567 · see citing works
Preclinical models: status of basic research in depression
Nestler, E. J., Gould, E., & Manji, H. K. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01405-1 · Cited by 559 · see citing works
Impaired Spatial Learning after Saturation of Long-Term Potentiation
Moser, E. I., Krobert, K. A., Moser, M.-B., & Morris, R. G. M. (1998) · Science · doi:10.1126/science.281.5385.2038 · Cited by 505 · see citing works
Initiation and adaptation: a paradigm for understanding psychotropic drug action
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.2.151 · Cited by 490 · see citing works
Behavioral stress modifies hippocampal plasticity through N-methyl-D-aspartate receptor activation.
Kim, J. J., Foy, M. R., & Thompson, R. F. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4750 · Cited by 435 · see citing works
Glutamate and Depression: Clinical and Preclinical Studies
PAUL, I. A., & SKOLNICK, P. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.016 · Cited by 408 · see citing works
Is it time to reassess the BDNF hypothesis of depression?
Groves, J. O. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002075 · Cited by 403 · see citing works
Heninger, G. R., Delgado, P. L., & Charney, D. S. (1996) · Pharmacopsychiatry · doi:10.1055/s-2007-979535 · Cited by 381 · see citing works
Adachi, M., Barrot, M., Autry, A. E., Theobald, D., & Monteggia, L. M. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.019 · Cited by 380 · see citing works
Antidepressants for the new millennium.
Skolnick, P. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00330-1 · Cited by 372 · see citing works
Biological rhythm disturbances in mood disorders
Wirz‐Justice, A. (2006) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000195660.37267.cf · Cited by 356 · see citing works
Neuroplasticity Mediated by Altered Gene Expression
McClung, C. A., & Nestler, E. J. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301544 · Cited by 347 · see citing works
Liu, G. (2004) · Nature Neuroscience · doi:10.1038/nn1206 · Cited by 339 · see citing works
Mathers, C. D., Stevenson, C., Vos, E. T., & Begg, S. J. (2000) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2000.tb124125.x · Cited by 339 · see citing works
Calcium regulation of gene expression in neuronal cells
Ghosh, A., Ginty, D. D., Bading, H., & Greenberg, M. E. (1994) · Journal of Neurobiology · doi:10.1002/neu.480250309 · Cited by 326 · see citing works
Roceri, M., Cirulli, F., Pessina, C., Peretto, P., Racagni, G., & Riva, M. A. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.12.011 · Cited by 317 · see citing works
Self-citationSignaling routes to CREM and CREB: plasticity in transcriptional activation
Cesare, D. D., Fimia, G. M., & Sassone‐Corsi, P. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01414-0 · Cited by 311 · see citing works
Acute Stress-induced Changes in Hippocampal/Prefrontal Circuits in Rats: Effects of Antidepressants
Rocher, C. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhg122 · Cited by 307 · see citing works
Tardito, D., Perez, J., Tiraboschi, E., Musazzi, L., Racagni, G., & Popoli, M. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.7 · Cited by 303 · see citing works
Self-citationLauterborn, J. C., LYNCH, G. S., Vanderklish, P. W., Arai, A., & Gall, C. M. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00008.2000 · Cited by 291 · see citing works
Svenningsson, P., Bateup, H. S., Qi, H., Takamiya, K., Huganir, R. L., Spedding, M., Roth, B. L., McEwen, B. S., & Greengard, P. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05952.x · Cited by 287 · see citing works
Venero, C., & Borrell, J. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00668.x · Cited by 277 · see citing works
Stahl, S. M. (1998) · PubMed · Cited by 260 · see citing works
Olié, J., & Kasper, S. F. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007766 · Cited by 257 · see citing works
Plasma and platelet excitatory amino acids in psychiatric disorders
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.11.1731 · Cited by 243 · see citing works
How can drug discovery for psychiatric disorders be improved?
Agid, Y., Buzsáki, G., Diamond, D. M., Frackowiak, R., Giedd, J., Girault, J.-A., Grace, A., Lambert, J. J., Manji, H., Mayberg, H., et al. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2217 · Cited by 240 · see citing works
Self-citationLearned helplessness in the rat: improvements in validity and reliability
Vollmayr, B., & Henn, F. A. (2001) · Brain Research Protocols · doi:10.1016/s1385-299x(01)00067-8 · Cited by 238 · see citing works
Bonanno, G., Giambelli, R., Raiteri, L., Tiraboschi, E., Zappettini, S., Musazzi, L., Raiteri, M., Racagni, G., & Popoli, M. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.5033-04.2005 · Cited by 234 · see citing works
Self-citationBagley, J., & Moghaddam, B. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00435-6 · Cited by 231 · see citing works
Clinical Applications of MAO-Inhibitors
Riederer, P. F., Lachenmayer, L., & Laux, G. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043364775 · Cited by 222 · see citing works
Lemoine, P., & Guilleminault, C. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n1112 · Cited by 217 · see citing works
Kennedy, S. H., Rizvi, S. J., Fulton, K., & Rasmussen, J. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318172b48c · Cited by 211 · see citing works
Reznikov, L. R., Grillo, C. A., Piroli, G. G., Pasumarthi, R. K., Reagan, L. P., & Fadel, J. R. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05560.x · Cited by 201 · see citing works
Montgomery, S. A., Kennedy, S. H., Burrows, G. D., Lejoyeux, M., & Hindmarch, I. (2004) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000137184.64610.c8 · Cited by 196 · see citing works
Balu, D. T., Hoshaw, B. A., Malberg, J. E., Rosenzweig-Lipson, S., Schechter, L. E., & Lucki, I. (2008) · Brain Research · doi:10.1016/j.brainres.2008.03.023 · Cited by 194 · see citing works
Antidepressant action: to the nucleus and beyond
Malberg, J. E., & Blendy, J. A. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.10.005 · Cited by 193 · see citing works
Nair, A., Vadodaria, K. C., Banerjee, S. B., Benekareddy, M., Dias, B. G., Duman, R. S., & Vaidya, V. A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301276 · Cited by 189 · see citing works
Berridge, C. W., Stratford, T. R., Foote, S. L., & Kelley, A. E. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199711)27:3 · Cited by 188 · see citing works
Tiraboschi, E., Tardito, D., Kasahara, J., Moraschi, S., Pruneri, P., Gennarelli, M., Racagni, G., & Popoli, M. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300488 · Cited by 186 · see citing works
Self-citationKole, M. H. P., Swan, L., & Fuchs, E. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02136.x · Cited by 181 · see citing works
Shakesby, A. C., Anwyl, R., & Rowan, M. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03638.2002 · Cited by 173 · see citing works
Major depressive disorder, sleep EEG and agomelatine: an open-label study
Quera-Salva, M.-A., Vanier, B., Laredo, J., Hartley, S., Chapotot, F., Moulin, C., Lofaso, F., & Guilleminault, C. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007754 · Cited by 170 · see citing works
Lee, B., Butcher, G. Q., Hoyt, K. R., Impey, S., & Obrietan, K. H. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4288-04.2005 · Cited by 165 · see citing works
Regulation of Cellular Plasticity Cascades in the Pathophysiology and Treatment of Mood Disorders
Zarate, C. A., Du, J., Quiroz, J. A., GRAY, N. A., Denicoff, K. D., Singh, J., Charney, D. S., & Manji, H. K. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.017 · Cited by 164 · see citing works
Boyer, P., Skolnick, P., & Fossom, L. H. (1998) · Journal of Molecular Neuroscience · doi:10.1007/bf02761776 · Cited by 157 · see citing works
Du, J., Gray, N. A., Falke, C. A., Chen, W., Yuan, P., Szabo, S. T., Einat, H., & Manji, H. K. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1258-04.2004 · Cited by 157 · see citing works
Stewart, C. A., & Reid, I. (2000) · Psychopharmacology · doi:10.1007/s002130050045 · Cited by 152 · see citing works
Brain-Derived Neurotrophic Factor and Antidepressant Activity
Russo‐Neustadt, A. A., & Chen, M. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053764788 · Cited by 152 · see citing works
Carola, V., Frazzetto, G., Pascucci, T., Audero, E., Puglisi‐Allegra, S., Cabib, S., Lesch, K., & Gross, C. T. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.08.013 · Cited by 141 · see citing works
Modulation of synaptic plasticity by stress and antidepressants
Popoli, M., Gennarelli, M., & Racagni, G. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01159.x · Cited by 139 · see citing works
Self-citationPattabiraman, P. P., Tropea, D., Chiaruttini, C., Tongiorgi, E., Cattaneo, A., & Domenici, L. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.11.010 · Cited by 132 · see citing works
Dynamic Multiphosphorylation Passwords for Activity-Dependent Gene Expression
Deisseroth, K. A., & Tsien, R. W. (2002) · Neuron · doi:10.1016/s0896-6273(02)00664-5 · Cited by 130 · see citing works
Stress, Metaplasticity, and Antidepressants
Garcia, R. (2002) · Current Molecular Medicine · doi:10.2174/1566524023362023 · Cited by 130 · see citing works
Strategies for producing faster acting antidepressants
Adell, A., Castro, E., Celada, P., Bortolozzi, A., Pazos, Á., & Artigas, F. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03398-2 · Cited by 129 · see citing works
Kasahara, J., Fukunaga, K., & Miyamoto, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100247200 · Cited by 127 · see citing works
Martínez-Turrillas, R. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00299-x · Cited by 122 · see citing works
Greisen, M. H., Altar, C. A., Bolwig, T. G., Whitehead, R. E., & Wörtwein, G. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20418 · Cited by 120 · see citing works
Sartorius, N., Baghai, T. C., Baldwin, D. S., Barrett, B. M., Brand, U., Fleischhacker, W., Goodwin, G. M., Grunze, H., Knapp, M. R. J., Leonard, B. E., et al. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008255 · Cited by 98 · see citing works
Qi, H., Mailliet, F., Spedding, M., Rocher, C., Zhang, X., Delagrange, P., McEwen, B. S., Jay, T. M., & Svenningsson, P. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.068 · Cited by 91 · see citing works
Ryan, B. K., Musazzi, L., Mallei, A., Tardito, D., Gruber, S. H. M., Khoury, A. E., Anwyl, R., Racagni, G., Mathé, A. A., Rowan, M. J., et al. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009607 · Cited by 79 · see citing works
Self-citationPittaluga, A., Raiteri, L., Longordo, F., Luccini, E., Barbiero, V. S., Racagni, G., Popoli, M., & Raiteri, M. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.04.006 · Cited by 76 · see citing works
Self-citationLarsen, M. H., Hay‐Schmidt, A., Rønn, L. C. B., & Mikkelsen, J. D. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.08.050 · Cited by 75 · see citing works
Tianeptine increases brain-derived neurotrophic factor expression in the rat amygdala
Reagan, L. P., Hendry, R. M., Reznikov, L. R., Piroli, G. G., Wood, G. E., McEwen, B. S., & Grillo, C. A. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.02.023 · Cited by 69 · see citing works
Khundakar, A. A., & Zetterström, T. (2006) · Brain Research · doi:10.1016/j.brainres.2006.05.063 · Cited by 67 · see citing works
Faure, J., Uys, J. D. K., Marais, L., Stein, D. J., & Daniels, W. M. U. (2007) · Metabolic Brain Disease · doi:10.1007/s11011-007-9048-3 · Cited by 65 · see citing works
Enhancing AMPA to NMDA throughput as a convergent mechanism for antidepressant action
Du, J., Machado-Vieira, R., Maeng, S., Martinowich, K., Manji, H. K., & Zarate, C. A. (2006) · Drug Discovery Today: Therapeutic Strategies · doi:10.1016/j.ddstr.2006.11.012 · Cited by 64 · see citing works
von Frijtag, J. C., Kamal, A., Reijmers, L. G. J. E., Schrama, L. H., van den Bos, R., & Spruijt, B. M. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02062-6 · Cited by 62 · see citing works
Tongiorgi, E., Domenici, L., & Simonato, M. (2005) · Molecular Neurobiology · doi:10.1385/mn:33:1:017 · Cited by 58 · see citing works
Holden, C. (2003) · Science · doi:10.1126/science.300.5627.1866 · Cited by 57 · see citing works
Kojima, T., Matsumoto, M., Togashi, H., Tachibana, K., Kemmotsu, O., & Yoshioka, M. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03756-3 · Cited by 56 · see citing works
The When and Where of BDNF and the Antidepressant Response
Wang, J., Dranovsky, A., & Hen, R. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.01.008 · Cited by 55 · see citing works
Ohashi, S., Matsumoto, M., Otani, H., Mori, K., Togashi, H., Ueno, K.-I., Kaku, A., & Yoshioka, M. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02973-6 · Cited by 54 · see citing works
Bouron, A., & Chatton, J. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00480-1 · Cited by 50 · see citing works
BMJ Publishing Group Ltd (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.089540 · Cited by 47 · see citing works
Mnie‐Filali, O., Mansari, M. E., Espana, A., Sánchez, C., & Haddjeri, N. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.10.044 · Cited by 45 · see citing works
Do Stress and Long-Term Potentiation Share the Same Molecular Mechanisms?
Huang, C., Yang, C., & Hsu, K. (2005) · Molecular Neurobiology · doi:10.1385/mn:32:3:223 · Cited by 44 · see citing works
New perspectives on the molecular pharmacology of affective disorders
Sulser, F. (1989) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf00449803 · Cited by 39 · see citing works
Tachibana, K., Matsumoto, M., Togashi, H., Kojima, T., Morimoto, Y., Kemmotsu, O., & Yoshioka, M. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2003.11.016 · Cited by 37 · see citing works
Matsumoto, M., Tachibana, K., Togashi, H., Tahara, K., Kojima, T., Yamaguchi, T., & Yoshioka, M. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2094-1 · Cited by 32 · see citing works
Time-dependent biphasic modulation of human BDNF by antidepressants in neuroblastoma cells
Donnici, L., Tiraboschi, E., Tardito, D., Musazzi, L., Racagni, G., & Popoli, M. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-61 · Cited by 32 · see citing works
Self-citationThe link between sleep and depression: The effects of antidepressants on EEG sleep
van Bemmel, A. L. (1997) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(97)00003-2 · Cited by 25 · see citing works
Tardito, D., Tiraboschi, E., Kasahara, J., Racagni, G., & Popoli, M. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706007140 · Cited by 25 · see citing works
Self-citationGoodwin, G. M., Rouillon, F., & Emsley, R. A. (2008) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(08)70471-1 · Cited by 13 · see citing works
Flagged first, then by citations
Research works printed but not linked: 6
- [2]Olesen J. Baker MG. Freund T. et al. Consensus document on European brain research. J Neurol Neurosurg Psychiatry. 2006 77(suppl 1) i1 i49 16845120 PMC3284269
- [6]Riederer P. Lachenmayer L. Laux G. Clinical applications of MAOinhibitors. Curr Med Chem. 2004 11 2033 2043 15279566
- [36]Malberg JE. Blendy JA. Antidepressant action: to the nucleus and beyond. Trends Pharmacol Sci. 2005 26 631 638 16246434
- [60]Rajkowska G. Miguel-Hidalgo JJ. Wei J. et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry. 1999 45 1085 1098 10331101
- [90]Timmerman W. Westerink BH. Brain microdialysis of GABA and glutamate: what does it signify?. Synapse. 1997 27 242 261 9329159
- [102]Maeng S. Zarate CA Jr. Du J. et al. Cellular mechanisms underlying t tidepressant effects of ketamine: role of alpha-amino-3-hydroxy- thylisoxazole-4-propionic acid receptors. Biol Psychiatry. 2008 63 349 35 17643398
Cited by
Sorted by citations
Towards a glutamate hypothesis of depression
Sanacora, G., Treccani, G., & Popoli, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.036 · Cited by 1,036 · see citing works
Self-citationThe Role of BDNF on Neural Plasticity in Depression
Yang, T., Nie, Z., Shu, H., Kuang, Y., Chen, X., Cheng, J., Yu, S., & Liu, H. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00082 · Cited by 435 · see citing works
Neural basis of major depressive disorder: Beyond monoamine hypothesis
Boku, S., Nakagawa, S., Toda, H., & Hishimoto, A. (2018) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12604 · Cited by 402 · see citing works
Epigenetic regulation of RAC1 induces synaptic remodeling in stress disorders and depression
Golden, S. A., Christoffel, D. J., Heshmati, M., Hodes, G. E., Magida, J., Davis, K., Cahill, M. E., Dias, C., Ribeiro, E., Ables, J. L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3090 · Cited by 322 · see citing works
From Serotonin to Neuroplasticity: Evolvement of Theories for Major Depressive Disorder
Liu, B., Liu, J., Wang, M., Zhang, Y., & Li, L. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00305 · Cited by 249 · see citing works
Godfrey, K. E. M., Gardner, A. C., Kwon, S., Chea, W., & Muthukumaraswamy, S. D. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.08.015 · Cited by 207 · see citing works
The Role of BDNF in the Neuroimmune Axis Regulation of Mood Disorders
Jin, Y., Sun, L., Yang, W., Cui, R., & Xu, S. B. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00515 · Cited by 200 · see citing works
Psychedelics and Other Psychoplastogens for Treating Mental Illness.
Vargas, M. V., Meyer, R., Avanes, A. A., Rus, M., & Olson, D. E. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.727117 · Cited by 166 · see citing works
MicroRNAs and exosomes in depression: Potential diagnostic biomarkers
Tavakolizadeh, J., Roshanaei, K., Salmaninejad, A., Yari, R., Nahand, J. S., Khoshdel‐Sarkarizi, H., Mousavi, S. M., Salarinia, R., Rahmati, M., Mousavi, S. F., et al. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26599 · Cited by 160 · see citing works
Ashe, K., Kelso, W. M., Farrand, S., Panetta, J., Fazio, T. N., Jong, G. D., & Walterfang, M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00561 · Cited by 156 · see citing works
GABAA receptor-acting neurosteroids: a role in the development and regulation of the stress response
Gunn, B. G., Cunningham, L., Mitchell, S. G., Swinny, J. D., Lambert, J. J., & Belelli, D. (2015) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.06.001 · Cited by 149 · see citing works
Blondeau, N., Nguemeni, C., Debruyne, D. N., Piens, M., Wu, X., Pan, H., Hu, X., Gandin, C., Lipsky, R. H., Plumier, J.-C., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.84 · Cited by 148 · see citing works
Sales, A. J., Biojone, C., Terceti, M. S., Guimarães, F. S., Gomes, M. V., & Joca, S. R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01489.x · Cited by 147 · see citing works
Sigma receptors: Potential targets for a new class of antidepressant drug
Fishback, J. A., Robson, M. J., Xu, Y., & Matsumoto, R. R. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.003 · Cited by 126 · see citing works
Sigma-1 receptor chaperones regulate the secretion of brain-derived neurotrophic factor
Fujimoto, M., Hayashi, T., Urfer, R., Mita, S., & Su, T.-P. (2012) · Synapse · doi:10.1002/syn.21549 · Cited by 124 · see citing works
Dual Role of Autophagy in Diseases of the Central Nervous System
Bar-Yosef, T., Damri, O., & Agam, G. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00196 · Cited by 126 · see citing works
Sartori, C. R., Vieira, A. S., Ferrari, E. M., Langone, F., Tongiorgi, E., & Parada, C. A. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.02.055 · Cited by 118 · see citing works
Fornaro, M., Prestía, D., Colicchio, S., & Perugi, G. (2010) · Current Neuropharmacology · doi:10.2174/157015910792246227 · Cited by 119 · see citing works
Aromatherapy and the Central Nerve System (CNS): Therapeutic Mechanism and its Associated Genes
Lv, X., Liu, Z., Zhang, H., & Tzeng, C. S. (2013) · Current Drug Targets · doi:10.2174/1389450111314080007 · Cited by 123 · see citing works
Pharmacogenetics of antidepressants
Crisafulli, C., Fabbri, C., Porcelli, S., Drago, A., Spina, E., De Ronchi, D., & Serretti, A. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00006 · Cited by 113 · see citing works
Stress, glucocorticoids and glutamate release: Effects of antidepressant drugs
Musazzi, L., Racagni, G., & Popoli, M. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.05.002 · Cited by 113 · see citing works
Self-citationZhong, H., Haddjeri, N., & Sánchez, C. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2463-5 · Cited by 105 · see citing works
An epigenome-wide DNA methylation study of PTSD and depression in World Trade Center responders
Kuan, P.-F., Waszczuk, M. A., Kotov, R., Marsit, C. J., Guffanti, G., Gonzalez, A., Yang, X., Koenen, K., Bromet, E., & Luft, B. J. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.130 · Cited by 103 · see citing works
Roles of glutamate signaling in preclinical and/or mechanistic models of depression
Tokita, K., Yamaji, T., & Hashimoto, K. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.04.016 · Cited by 103 · see citing works
Prins, J., Olivier, B., & Korte, S. M. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.594039 · Cited by 98 · see citing works
Melvin, S. D. (2016) · Aquatic Toxicology · doi:10.1016/j.aquatox.2016.11.007 · Cited by 94 · see citing works
Common mechanisms of pain and depression: are antidepressants also analgesics?
Nekovářová, T., Yamamotová, A., Valeš, K., Stuchlı́k, A., Fricová, J., & Rokyta, R. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00099 · Cited by 88 · see citing works
Maina, G., Rosso, G., Zanardini, R., Bogetto, F., Gennarelli, M., & Bocchio‐Chiavetto, L. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.07.009 · Cited by 89 · see citing works
Ketamine’s antidepressant effect is mediated by energy metabolism and antioxidant defense system
Weckmann, K., Deery, M. J., Howard, J. A., Feret, R., Asara, J. M., Dethloff, F., Filiou, M. D., Iannace, J., Labermaier, C., Maccarrone, G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16183-x · Cited by 91 · see citing works
The role of the neuroendocrine and immune systems in the pathogenesis of depression
Ogłodek, E., Szota, A. M., Just, M. J., Moś, D., & Araszkiewicz, A. S. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.04.009 · Cited by 87 · see citing works
Onset, time course and trajectories of improvement with antidepressants
Lam, R. W. M. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.07.005 · Cited by 84 · see citing works
G protein-linked signaling pathways in bipolar and major depressive disorders
Tomita, H., Ziegler, M. E., Kim, H. B., Evans, S. J., Choudary, P. V., Li, J. Z., Meng, F., Dai, M., Myers, R., Neal, C. R., et al. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00297 · Cited by 81 · see citing works
Agomelatine, a novel intriguing antidepressant option enhancing neuroplasticity: A critical review
Pompili, M., Serafini, G., Innamorati, M., Venturini, P., Fusar‐Poli, P., Sher, L., Amore, M., & Girardi, P. (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.765593 · Cited by 78 · see citing works
Xue, W., Zhou, X., Yi, N., Jiang, L., Tao, W., Wu, R., Wang, D., Jiang, J., Ge, X., Wang, Y., et al. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/184367 · Cited by 77 · see citing works
Protti, M., Mandrioli, R., Marasca, C., Cavalli, A., Serretti, A., & Mercolini, L. (2020) · Medicinal Research Reviews · doi:10.1002/med.21671 · Cited by 71 · see citing works
Trehalose induced antidepressant-like effects and autophagy enhancement in mice
Kara, N., Toker, L., Agam, G., Anderson, G. W., Belmaker, R. H., & Einat, H. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3119-4 · Cited by 73 · see citing works
Leuchter, A. F., Hunter, A. M., Krantz, D. E., & Cook, I. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12742 · Cited by 71 · see citing works
Lisoway, A. J., Zai, C. C. H., Tiwari, A. K., & Kennedy, J. L. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2016.12.071 · Cited by 66 · see citing works
Sales, A. J., & Joca, S. R. L. (2016) · Acta Neuropsychiatrica · doi:10.1017/neu.2015.40 · Cited by 62 · see citing works
Molecular Neurobiology and Promising New Treatment in Depression
Jeon, S. R., & Kim, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030381 · Cited by 61 · see citing works
Fluoxetine Exposure during Adolescence Alters Responses to Aversive Stimuli in Adulthood
Iñiguez, S. D., Parise, L. F., Warren, B. L., Riggs, L. M., Parise, E. M., Vialou, V., Wright, K. N., Dayrit, G., Nieto, S. J., Wilkinson, M. B., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.5725-12.2014 · Cited by 59 · see citing works
Update on GPCR-based targets for the development of novel antidepressants
Mantas, I., Saarinen, M., Xu, Q., & Svenningsson, P. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01040-1 · Cited by 59 · see citing works
Golan, M., Schreiber, G., & Avissar, S. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001550 · Cited by 54 · see citing works
Möller, H. ‐., Bitter, I., Bobes, J., Fountoulakis, K. Ν., Höschl, C., & Kasper, S. F. (2011) · European Psychiatry · doi:10.1016/j.eurpsy.2011.08.002 · Cited by 53 · see citing works
Silva, M., de Aguiar, D. C., Diniz, C. R. A. F., Guimarães, F. S., & Joca, S. R. L. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9775-1 · Cited by 52 · see citing works
Gupta, D., Radhakrishnan, M., & Kurhe, Y. (2015) · Steroids · doi:10.1016/j.steroids.2015.01.021 · Cited by 52 · see citing works
The dose makes the poison: From glutamate-mediated neurogenesis to neuronal atrophy and depression
Rubio-Casillas, A., & Fernández-Guasti, A. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2015-0066 · Cited by 49 · see citing works
Jiang, B., Wang, W., Wang, F., Hu, Z., Xiao, J., Yang, S., Zhang, J., Peng, X., Wang, J., & Chen, J. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.10.031 · Cited by 46 · see citing works
Yosaee, S., Clark, C. C. T., Keshtkaran, Z., Ashourpour, M., Keshani, P., & Soltani, S. (2020) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2020.08.001 · Cited by 48 · see citing works
Yan, T., Wang, L., Kuang, W., Xu, J., Li, S., Chen, J., & Yang, Y. (2014) · Asia-Pacific Psychiatry · doi:10.1111/appy.12148 · Cited by 46 · see citing works
Targeting astrocytes in bipolar disorder
Peng, L., Li, B., & Verkhratsky, A. (2016) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2016.1171144 · Cited by 46 · see citing works
Early induction of CREB activation and CREB-regulating signalling by antidepressants
Tardito, D., Musazzi, L., Tiraboschi, E., Mallei, A., Racagni, G., & Popoli, M. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709000376 · Cited by 42 · see citing works
Self-citationFabbri, C., Marsano, A., Albani, D., Chierchia, A., Calati, R., Drago, A., Crisafulli, C., Calabrò, M., Kasper, S. F., Lanzenberger, R. R., et al. (2014) · The Pharmacogenomics Journal · doi:10.1038/tpj.2014.15 · Cited by 41 · see citing works
Klomp, A., Tremoleda, J. L., Wylezinska, M., Nederveen, A. J., Feenstra, M. G. P., Gsell, W., & Reneman, L. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.07.082 · Cited by 41 · see citing works
Musazzi, L., Rimland, J. M., Ieraci, A., Racagni, G., Domenici, E., & Popoli, M. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001685 · Cited by 39 · see citing works
Self-citationRare susceptibility variants for bipolar disorder suggest a role for G protein-coupled receptors
Cruceanu, C., Schmouth, J.-F., Torres-Platas, S. G., López, J. P., Ambalavanan, A., Darcq, E., Gross, F., Breton, B., Spiegelman, D., Rochefort, D. L., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.223 · Cited by 38 · see citing works
Isotretinoin has no negative effect on attention, executive function and mood
Ergun, T., Seçkin, D., Özaydın, A., Bakar, Ö., Cömert, A., Atsü, N., Demirçay, Z., Yöney, H., & Zaimoğlu, S. (2011) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2011.04089.x · Cited by 38 · see citing works
Ludka, F. K., Dal-Cim, T. A., Binder, L. B., Constantino, L. C., Massari, C. M., & Tasca, C. I. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9882-6 · Cited by 38 · see citing works
Álvarez-Mon, M. Á., Ortega, M. A., Montero, C. G., Fraile‐Μartinez, O., Monserrat, J., Lahera, G., Mora, F., Rodríguez-Quiroga, A., Fernández-Rojo, S., Quintero, J., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14080821 · Cited by 36 · see citing works
A novel peripheral biomarker for depression and antidepressant response
Targum, S. D., Schappi, J. M., Koutsouris, A., Bhaumik, R., Rapaport, M. H., Rasgon, N., & Rasenick, M. M. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01399-1 · Cited by 38 · see citing works
Clinical features and drug induced side effects in early versus late antidepressant responders
Fabbri, C., Marsano, A., Balestri, M., Ronchi, D. D., & Serretti, A. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.020 · Cited by 33 · see citing works
Advances in novel molecular targets for antidepressants
Wang, Q., & Dwivedi, Y. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110041 · Cited by 32 · see citing works
Fry, J. P., Li, K. Y., Devall, A., Cockcroft, S., Honour, J. W., & Lovick, T. A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12891 · Cited by 31 · see citing works
Antidepressants and type 2 diabetes: highways to knowns and unknowns
Alruwaili, N. S., Al-Kuraishy, H. M., Al-Gareeb, A. I., Albuhadily, A. K., Ragab, A. E., Alenazi, A. A., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01149-z · Cited by 30 · see citing works
Zhang, L., Wang, X., Zhao, N., Wang, Y., Hu, X., Ran, Y., Liu, Y., Zhang, Y., Yang, R., & Li, Y. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13675 · Cited by 30 · see citing works
Rosas-Sánchez, G. U., Germán-Ponciano, L. J., Guillén-Ruiz, G., Cueto‐Escobedo, J., Limón-Vázquez, A. K., Rodríguez‐Landa, J. F., & Soria-Fregozo, C. (2024) · Biomedicines · doi:10.3390/biomedicines12122744 · Cited by 30 · see citing works
Psychiatric neural networks and neuropharmacology: Selected advances and novel implications
Ghanemi, A. (2013) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2013.01.008 · Cited by 27 · see citing works
The intersection of pharmacology, imaging, and genetics in the development of personalized medicine
Gerretsen, P., Müller, D. J., Tiwari, A. K., Mamo, D. C., & Pollock, B. G. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.4/pgerretsen · Cited by 27 · see citing works
Wang, X., Chen, J., Zhang, H., Huang, Z., Zou, Z., Yin, C., Sheng, L., Xue, W., Tang, J., Wu, H., et al. (2018) · Bioscience Reports · doi:10.1042/bsr20181539 · Cited by 26 · see citing works
Germán-Ponciano, L. J., Rosas-Sánchez, G. U., Cueto‐Escobedo, J., Fernández-Demeneghi, R., Guillén-Ruiz, G., Soria-Fregozo, C., Herrera-Huerta, E. V., & Rodríguez‐Landa, J. F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810896 · Cited by 26 · see citing works
Monoamine involvement in the antidepressant-like effect induced by P2 blockade
Diniz, C. R. A. F., Rodrigues, M., Casarotto, P. C., Pereira, V. S., Crestani, C. C., & Joca, S. R. L. (2017) · Brain Research · doi:10.1016/j.brainres.2017.09.011 · Cited by 25 · see citing works
Zemanová, N., Anzenbacher, P., & Anzenbacherová, E. (2022) · Biomedical Papers · doi:10.5507/bp.2022.019 · Cited by 25 · see citing works
The Role of Beta-Adrenergic Receptors in Depression and Resilience
Zhang, H., Cui, M., Cao, J., & Han, M. (2022) · Biomedicines · doi:10.3390/biomedicines10102378 · Cited by 25 · see citing works
Kingir, E., Sevinc, C., & Ünal, G. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109468 · Cited by 25 · see citing works
Golan, M., Schreiber, G., & Avissar, S. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.160218 · Cited by 24 · see citing works
Sołek, P., Koszła, O., Mytych, J., Badura, J., Chelminiak, Z., Cuprys, M., Fraczek, J., Tabęcka-Łonczyńska, A., & Koziorowski, M. (2019) · APOPTOSIS · doi:10.1007/s10495-019-01557-5 · Cited by 24 · see citing works
Molecular and Cellular Aspects of Major Depressive Disorder
Chottekalapanda, R. U., Greengard, P., & Sagi, Y. (2019) · doi:10.1093/oso/9780190455132.003.0004 · Cited by 23 · see citing works
Foshati, S., Ghanizadeh, A. J., & Akhlaghi, M. (2021) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2021.07.016 · Cited by 23 · see citing works
All roads lead to glutamate: NMDA and AMPA receptors as targets for rapid-acting antidepressants
Freudenberg, F., Reif-Leonhard, C., Dawson, G. R., McKernan, R. M., & Reif, A. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107918 · Cited by 23 · see citing works
Diniz, C. R. A. F., Casarotto, P. C., & Joca, S. R. L. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.03.037 · Cited by 22 · see citing works
New Therapeutic Strategy for Mood Disorders
Crupi, R., Marino, A., & Cuzzocrea, S. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711797200417 · Cited by 20 · see citing works
Dong, X. Y., Liu, L., Li, Y., Ruan, J., & Wang, H. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02840-2 · Cited by 22 · see citing works
Li, Q., Gao, Y., Li, H., Liu, H., Wang, D., Pan, W. X., Liu, S., & Xu, Y. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.07.037 · Cited by 21 · see citing works
Saracino, M. A., Mercolini, L., Carbini, G., Volterra, V., Quarta, A. L., Amore, M., & Raggi, M. A. (2014) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2014.02.005 · Cited by 21 · see citing works
Golan, M., Schreiber, G., & Avissar, S. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000291 · Cited by 21 · see citing works
Yoga in major depressive disorder: molecular mechanisms and clinical utility
Tolahunase, M., Gautam, S., Sagar, R., Kumar, M., & Dada, R. (2021) · Frontiers in Bioscience-Scholar · doi:10.52586/s553 · Cited by 22 · see citing works
Research progress on vesicle cycle and neurological disorders
Zhang, C., Zhu, L., & Chen, C. (2021) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/jpps31458 · Cited by 20 · see citing works
Lee, J. S., Bainter, S. A., Tsai, A. C., Andersen, L. S., Stanton, A. M., Magidson, J. F., Kagee, A., Joska, J. A., O’Cleirigh, C. M., & Safren, S. A. (2022) · AIDS and Behavior · doi:10.1007/s10461-022-03906-z · Cited by 20 · see citing works
Chronic Fluoxetine Treatment of Socially Isolated Rats Modulates Prefrontal Cortex Proteome
Filipović, D., Novak, B., Xiao, J., Yan, Y., Yeoh, K., & Turck, C. W. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.08.011 · Cited by 20 · see citing works
Astroglia, Glutamatergic Transmission and Psychiatric Diseases
Verkhratsky, A., Steardo, L., Peng, L., & Parpura, V. (2016) · Advances in neurobiology · doi:10.1007/978-3-319-45096-4_12 · Cited by 18 · see citing works
Lyman, K. A., Han, Y., Zhou, C., Renteria, I., Besing, G.-L., Kurz, J. E., & Chetkovich, D. M. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abl4580 · Cited by 17 · see citing works
Zhao, X., Li, H., & Dai, R. (2022) · World Journal of Psychiatry · doi:10.5498/wjp.v12.i3.379 · Cited by 17 · see citing works
Marcin, L. R., Warrier, J., Thangathirupathy, S., Shi, J., Karageorge, G. N., Pearce, B. C., Ng, A., Park, H., Kempson, J., Li, J., et al. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00080 · Cited by 17 · see citing works
Dawson, G. R., Post, A., Smart, T. S., Browning, M. D., & Harmer, C. J. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211044684 · Cited by 17 · see citing works
Wheatgrass extract imparts neuroprotective actions against scopolamine-induced amnesia in mice
Katiyar, P., Rathore, A. S., Banerjee, S., Nathani, S., Zahra, W., Singh, S. P., Sircar, D., & Roy, P. (2022) · Food & Function · doi:10.1039/d2fo00423b · Cited by 16 · see citing works
Zhang, Y., Jin, C., Wang, X., Shen, M., Zhou, J., Wu, S., Fu, Z., & Jin, Y. (2018) · Environmental Toxicology · doi:10.1002/tox.22653 · Cited by 16 · see citing works
Chukaew, P., Leow, A., Saengsawang, W., & Rasenick, M. M. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0724-6 · Cited by 16 · see citing works
Aswar, U. M., ., P. K., Shelke, S. M., Bhosale, S. H., & Bodhankar, S. L. (2012) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/s2221-1691(13)60012-x · Cited by 16 · see citing works
Khlebnikova, N. N., Krupina, N. A., Kushnareva, E. Y., Золотов, Н. Н., & Крыжановский, Г. Н. (2012) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-012-1540-z · Cited by 14 · see citing works
Filipović, D., Costina, V., Findeisen, P., & Inta, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315351 · Cited by 13 · see citing works
- Authors
- Racagni, G., & Popoli, M.
- Affiliations
- University of Milan (IT)
- Corresponding author
- Popoli, Maurizio
- Venue
- Dialogues in Clinical Neuroscience
- Publisher
- Informa UK Limited
- Published
- 2008-12-31
- Volume
- 10
- Issue
- 4
- Pages
- 385-400
- ISSN
- 1294-8322 (ISSN-L)
- 1958-5969
- PMC
- PMC3181899
- OpenAlex
- W2095618681
- Cited by
- 192
- References
- 125
- Citations by year
- 2026: 6 · 2025: 26 · 2024: 12 · 2023: 5 · 2022: 14 · 2021: 13 · 2020: 7 · 2019: 7 · 2018: 5 · 2017: 10 · 2016: 13 · 2015: 8 · 2014: 16 · 2013: 10 · 2012: 10
- FWCI
- 7.03
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- Locations
- Dialogues in Clinical Neuroscience (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- antidepressants, depression, mood disorders, neuroplasticity, antidepressant mechanism, monoamine hypothesis, gene expression, neurotrophic factors, synaptic plasticity, synaptic transmission, neurogenesis
- MeSH terms
- Animals, Antidepressive Agents, Depressive Disorder, Humans, Synaptic Transmission, Neuronal Plasticity, Neurons, Biogenic Monoamines, Brain-Derived Neurotrophic Factor, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review